# Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin

> **NCT00269061** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 32 (—)

## Conditions studied

- Non-Insulin-Dependent Diabetes Mellitus

## Interventions

- **DRUG:** pioglitazone

## Key facts

- **NCT ID:** NCT00269061
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 32 (—)
- **Last updated:** 2008-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00269061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00269061, "Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00269061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*